With respect to HLA-C molecule, patients with higher expression of mismatched HLA-C tended to suffer from higher risk of actue GVHD (III-IV) and nonrelapse mortality compared with those with lower expression mismatches. The gene discussed is HLA-C; the disease is graft versus host disease.